trending Market Intelligence /marketintelligence/en/news-insights/trending/oeugelaf4_1srv8vac3qqg2 content esgSubNav
In This List

AIT Therapeutics to change fiscal year-end to March 31

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


AIT Therapeutics to change fiscal year-end to March 31

AIT Therapeutics, Inc.'s board has approved to change the company's fiscal year-end to March 31 from Dec. 31.

The change becomes effective as of March 31, the New York-based medical device maker said in an SEC filing.

AIT plans to file a Form 10-KT covering the three-month transition period from Jan. 1 to March 31 on or before Aug. 8, it said in the filing.